Asthma News

Social, economic and environmental factors at individual and neighborhood levels mediated racial disparities in pediatric visits to the ED related to asthma, according to a study published in The Journal of Allergy and Clinical Immunology.

U.S. health care spending on respiratory conditions, especially chronic conditions like asthma and COPD, increased dramatically from 1996 to 2016, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

Single maintenance and reliever therapy, also known as SMART or single-inhaler therapy, significantly reduces asthma exacerbation frequency and severity, according to a review published in Annals of Allergy, Asthma & Immunology.

Members of racial and ethnic communities that have been oppressed structurally may face increased burdens of allergic and atopic disease, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.

Early onset persistent asthma and late onset asthma have distinct phenotypes with different features and comorbidities impacting disease control, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Workers who participated in the cleanup of the Deepwater Horizon oil spill experienced an increased risk for asthma due to exposure to total hydrocarbons and PM2.5 air pollutants, according to a study published in Environment International.

Patients with rhinitis and rhinosinusitis frequently suffered from comorbidities that imposed a significant burden on outpatient care, according to a study published in Clinical and Translational Allergy.

About two-thirds of patients who began biologics for asthma exacerbations had suboptimal adherence to maintenance medication in the prior year, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

In a new study published in Pediatrics, researchers concluded that children with asthma have similar risk for for SARS-CoV-2 infection compared with children without asthma.

Phenotype-directed mepolizumab therapy reduced the number of asthma exacerbations among children and adolescents with exacerbation-prone eosinophilic asthma who live in disadvantaged urban neighborhoods, researchers reported in The Lancet.